预测患有多动症的儿童和青少年对甲基酸盐的反应:系统性审查
Maryse Pagnier1,2,3
1Université Paris Cité, Paris, France.
Journal of attention disorders
|May 27, 2023
概括
在ADHD中预测甲基化物 (MPH) 反应是具有挑战性的. 目前的证据表明,没有明确的患者特征可靠地预测这种常见的多动症治疗药物的个体治疗成功.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 儿童和青少年精神病学
背景情况:
- 注意缺陷/多动障碍 (ADHD) 是儿童和青少年中普遍存在的一种神经发育障碍.
- 甲基化物 (MPH) 是ADHD的第一线药理疗法.
- 识别MPH反应的预测因素对于个性化治疗策略至关重要.
结论:
- 目前没有可靠的个体患者特征可以预测ADHD中甲基胺的反应.
- 需要进一步的研究来识别和验证MPH反应的预测因素.
- 建议在未来的研究中对潜在预测因子进行标准化测量,以控制MPH响应建模中的混变量.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.8K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.4K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
133
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
133
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
